Elutia to Participate in Upcoming Investor Conferences
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Elutia (Nasdaq: ELUT), a drug-eluting biomatrix technologies company, has announced its participation in three upcoming investor conferences in New York this September.
The company's leadership, including CEO Dr. Randy Mills and CFO Matt Ferguson, will attend the Cantor Global Healthcare Conference (Sept. 4), the H.C. Wainwright Global Investment Conference (Sept. 10), and the Lake Street Capital Markets Best Ideas Growth Conference (Sept. 11). The first two events will feature fireside chats and presentations, while the Lake Street conference will focus on one-on-one meetings.
Details
News Market Reaction – ELUT
On Aug 27, the day this news came out, ELUT closed 7.92% below the previous close. That session’s volume was 3.1x the stock’s average daily volume.
Data tracked by StockTitan Argus for the Aug 27 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
GAITHERSBURG, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, President and Chief Executive Officer, and Matt Ferguson, Chief Financial Officer, will participate in the following upcoming investor conferences in New York:
Cantor Global Healthcare Conference
Format: Fireside Chat and 1x1 Meetings
Fireside Chat Date and Time: Thursday, September 4, 2025, 9:45 a.m. ET
Webcast Link: Click Here
H.C. Wainwright 27th Annual Global Investment Conference
Format: Presentation and 1x1 Meetings
Presentation Date and Time: Wednesday, September 10, 2025, 9:30 a.m. ET
Webcast Link: Click Here
Lake Street Capital Markets 9th Annual Best Ideas Growth Conference
Format: 1x1 Meetings
Date: Thursday, September 11, 2025
Institutional investors interested in scheduling a meeting may contact their Cantor, H.C. Wainwright, or Lake Street representative or email IR@elutia.com.
About Elutia
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.
Investors:
Matt Steinberg
FINN Partners
matt.steinberg@finnpartners.com
This press release was published by a CLEAR® Verified individual.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.